Research
Receptor map uncovers hidden sites that could guide asthma drug design
The Brief
- Researchers at the Center for Genomic Regulation (CRG) developed a new method for identifying previously unknown druggable sites on a family of receptor proteins.
- The approach is aimed at designing treatments with fewer side effects for conditions ranging from heart disease to depression.
- The work was reported by Medical Xpress on 2026-11-11.
Why it matters
Identifying hidden binding sites on receptor proteins could open new routes for drug design, potentially reducing side effects across many conditions.
Who’s affected
- drug discovery researchers
- pharmacologists
- asthma patients and clinicians interested in future treatments
- #receptors
- #drug discovery
- #druggable sites
- #pharmacology
- #asthma
Researchers at the Center for Genomic Regulation (CRG) have developed a new way of identifying new druggable sites on a family of proteins that could help design treatments with fewer side effects for a very wide range of conditions from heart disease to depression.
Timeline
Medical Xpress reports the CRG receptor mapping study
Medical Xpress - latest medical and health news stories
Receptor map uncovers hidden sites that could guide asthma drug design